This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Arrowhead Pharmaceuticals, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Yichen Wang: Innovator in RNAi Therapeutics
Introduction
Yichen Wang is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of RNA interference (RNAi) therapeutics. With a focus on innovative solutions for complex medical conditions, he has been instrumental in developing novel pharmaceutical compositions that target specific gene expressions.
Latest Patents
Yichen Wang holds 2 patents that showcase his expertise in RNAi technology. His latest patents include:
1. **RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use** - This patent discloses RNAi agents capable of inhibiting CFB gene expression. It also details pharmaceutical compositions that incorporate these agents, which may be conjugated to targeting ligands for enhanced delivery to hepatocyte cells. The applications of these RNAi agents extend to various diseases, including IgA nephropathy, lupus nephritis, and age-related macular degeneration.
2. **RNAi agents for inhibiting expression of complement component C3 (C3), pharmaceutical compositions thereof, and methods of use** - This patent focuses on RNAi agents that inhibit C3 gene expression. Similar to the previous patent, it includes pharmaceutical compositions and methods for treating diseases associated with C3 gene expression, such as C3 glomerulopathy and paroxysmal nocturnal hemoglobinuria.
Career Highlights
Yichen Wang is currently employed at Arrowhead Pharmaceuticals, Inc., where he continues to advance his research in RNAi therapeutics. His work is characterized by a commitment to developing innovative treatments that address unmet medical needs.
Collaborations
Throughout his career, Yichen has collaborated with notable colleagues, including Tao Pei and Jeffrey Carlson. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Yichen Wang's contributions to RNAi therapeutics exemplify the impact of innovative thinking in medicine. His patents reflect a dedication to improving treatment options for patients with complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile